Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.00
-0.12 (-2.34%)
At close: Apr 28, 2026, 4:00 PM EDT
5.10
+0.10 (2.00%)
After-hours: Apr 28, 2026, 7:20 PM EDT

Opus Genetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-49.59-57.53-9.9917.89-56.69
Upgrade
Depreciation & Amortization
0.050.010.0100
Upgrade
Asset Writedown & Restructuring Costs
-28---
Upgrade
Loss (Gain) From Sale of Investments
00.010.030.170.07
Upgrade
Stock-Based Compensation
3.43.363.511.811.91
Upgrade
Other Operating Activities
13.04-2.521.25-35.15
Upgrade
Change in Accounts Receivable
2.61-3.442.52-4.85-
Upgrade
Change in Accounts Payable
0.010.221.08-0.520.38
Upgrade
Change in Other Net Operating Assets
-4.776.310.48-0.19-0.2
Upgrade
Operating Cash Flow
-35.25-25.58-1.1114.31-19.37
Upgrade
Capital Expenditures
-----0.1
Upgrade
Other Investing Activities
-1.21---
Upgrade
Investing Cash Flow
-1.21---0.1
Upgrade
Short-Term Debt Issued
----0.65
Upgrade
Long-Term Debt Issued
1----
Upgrade
Total Debt Issued
1---0.65
Upgrade
Short-Term Debt Repaid
----0.54-0.11
Upgrade
Total Debt Repaid
----0.54-0.11
Upgrade
Net Debt Issued (Repaid)
1---0.540.54
Upgrade
Issuance of Common Stock
35.964.59.264.4628.58
Upgrade
Repurchase of Common Stock
-0.15-0.08---
Upgrade
Other Financing Activities
13.22-0.23-0.28-0.13-1.51
Upgrade
Financing Cash Flow
50.024.198.983.7927.61
Upgrade
Net Cash Flow
14.77-20.187.8718.18.14
Upgrade
Free Cash Flow
-35.25-25.58-1.1114.31-19.47
Upgrade
Free Cash Flow Margin
-248.33%-232.68%-5.84%35.92%-3305.60%
Upgrade
Free Cash Flow Per Share
-0.57-0.96-0.050.69-1.31
Upgrade
Cash Interest Paid
---0.010
Upgrade
Cash Income Tax Paid
--0.34--
Upgrade
Levered Free Cash Flow
-23.77-13.530.247.64-12.29
Upgrade
Unlevered Free Cash Flow
-22.85-13.531.077.65-12.29
Upgrade
Change in Working Capital
-2.153.094.08-5.560.18
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.